SCYX

Conviction 76HealthcareScan · Fri, Jun 26, 2026

SCYX$3.77-1.18%

ResistanceSupportVol 14

Vol MA14 78.42K

Mar 27Apr 15May 4May 20Jun 9Jun 26

SCYNEXIS INCPHARMACEUTICAL PREPARATIONSwww.scynexis.com ↗

Price3.77

Change-1.18%

Gap-0.26%

Rel volume0.88×

Avg volume103.41K

Avg $ vol348.22K

SMA 204.10

SMA 502.17

SMA 2001.12

Price vs 50+73.69%

Price vs 200+234.99%

MA stackbullish

50/200 cross—

Supertrendup · 3.68

RSI (14)59

MACD hist-0.16

MACD crossbear · 6d

Stoch %K / %D8 / 10

ADX (14)42

+DI / −DI30 / 18

RSI divergence—

MACD divergence—

ATR %+8.44%

ADR %7.44%

52w high5.33

52w low0.5773

From 52w high-29.36%

Above 52w low+552.17%

New 52w highNo

SqueezeOff

Bollinger width87.57%

%B0.41

Donchian pos62.27%

Donchian high5.62

Donchian low0.7036

AVWAP (52w high)4.32

vs AVWAP high-12.85%

AVWAP (52w low)0.8616

vs AVWAP low+336.96%

OBV trendDown

Chaikin MF (20)-0.43

Today vs 20d0.88×

Avg vol (14d)78.42K

Avg vol (20d)103.41K

Avg $ vol (20d)348.22K

Market cap—

RS 3m (vs SPY)+320.77%

RS 6m (vs SPY)+514.82%

RS line new highNo

Trend template7/8

Technical rank94.1

1 week-7.04%

1 month+437.17%

3 months+349.55%

6 months+543.92%

1 year+402.67%

YTD+489.66%

P/E-34.97

P/B7.29

P/S14.62

P/FCF-56.99

EPS-0.1700

Div yield—

ROE-20.84%

ROA-11.09%

Debt/Eq0.00

Current3.94

EV/EBITDA-16.45

Gross margin17.37%

Net margin-41.79%

Rev growth449.95%

EPS growth59.56%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value264.42M

Revenue0

Net income-21.3M

Gross profit66K

Free cash flow-5.28M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees29

ListedFri, May 2, 2014

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction76 / 100

Pattern quality—

Tech rank94.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.33

Support0.6814

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SCYX

All disclosures →

No recent disclosed trades by Congress in SCYX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SCYX

No recent insider (Form 4) filings in SCYX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in SCYX

EDGAR →

No recent SEC filings on file for SCYX.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.